Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Evaluation of gastrointestinal injury and blood flow of small bowel during low-dose aspirin administration.

Nishida U, Kato M, Nishida M, Kamada G, Ono S, Shimizu Y, Fujimori S, Asaka M.

J Clin Biochem Nutr. 2011 May;48(3):245-50. doi: 10.3164/jcbn.10-112.

2.

Evaluation of small bowel blood flow in healthy subjects receiving low-dose aspirin.

Nishida U, Kato M, Nishida M, Kamada G, Yoshida T, Ono S, Shimizu Y, Asaka M.

World J Gastroenterol. 2011 Jan 14;17(2):226-30. doi: 10.3748/wjg.v17.i2.226.

3.

Low-dose aspirin affects the small bowel mucosa: results of a pilot study with a multidimensional assessment.

Smecuol E, Pinto Sanchez MI, Suarez A, Argonz JE, Sugai E, Vazquez H, Litwin N, Piazuelo E, Meddings JB, Bai JC, Lanas A.

Clin Gastroenterol Hepatol. 2009 May;7(5):524-9. doi: 10.1016/j.cgh.2008.12.019.

PMID:
19249402
4.

Randomized, double-blind, pilot study of geranylgeranylacetone versus placebo in patients taking low-dose enteric-coated aspirin. Low-dose aspirin-induced small bowel damage.

Shiotani A, Haruma K, Nishi R, Fujita M, Kamada T, Honda K, Kusunoki H, Hata J, Graham DY.

Scand J Gastroenterol. 2010 Mar;45(3):292-8. doi: 10.3109/00365520903453182.

PMID:
19968611
5.

Incidence of small bowel injury induced by low-dose aspirin: a crossover study using capsule endoscopy in healthy volunteers.

Endo H, Hosono K, Inamori M, Kato S, Nozaki Y, Yoneda K, Akiyama T, Fujita K, Takahashi H, Yoneda M, Abe Y, Kirikoshi H, Kobayashi N, Kubota K, Saito S, Matsuhashi N, Nakajima A.

Digestion. 2009;79(1):44-51. doi: 10.1159/000204465.

PMID:
19246922
6.

Differences in the severity of small bowel mucosal injury based on the type of aspirin as evaluated by capsule endoscopy.

Endo H, Sakai E, Higurashi T, Yamada E, Ohkubo H, Iida H, Koide T, Yoneda M, Abe Y, Inamori M, Hosono K, Takahashi H, Kubota K, Nakajima A.

Dig Liver Dis. 2012 Oct;44(10):833-8. doi: 10.1016/j.dld.2012.05.016.

PMID:
22749649
7.

Small bowel injury in low-dose aspirin users.

Endo H, Sakai E, Kato T, Umezawa S, Higurashi T, Ohkubo H, Nakajima A.

J Gastroenterol. 2015 Apr;50(4):378-86. doi: 10.1007/s00535-014-1028-x. Review.

PMID:
25501289
8.

Determination of the adequate dosage of rebamipide, a gastric mucoprotective drug, to prevent low-dose aspirin-induced gastrointestinal mucosal injury.

Ota K, Takeuchi T, Nouda S, Ozaki H, Kawaguchi S, Takahashi Y, Harada S, Edogawa S, Kojima Y, Kuramoto T, Higuchi K.

J Clin Biochem Nutr. 2016 Nov;59(3):231-237.

9.

Small bowel injury by low-dose enteric-coated aspirin and treatment with misoprostol: a pilot study.

Watanabe T, Sugimori S, Kameda N, Machida H, Okazaki H, Tanigawa T, Watanabe K, Tominaga K, Fujiwara Y, Oshitani N, Higuchi K, Arakawa T.

Clin Gastroenterol Hepatol. 2008 Nov;6(11):1279-82. doi: 10.1016/j.cgh.2008.06.021.

PMID:
18995219
10.

Enteric coating of aspirin significantly decreases gastroduodenal mucosal lesions.

Dammann HG, Burkhardt F, Wolf N.

Aliment Pharmacol Ther. 1999 Aug;13(8):1109-14.

12.

Risk factors for small-bowel mucosal breaks in chronic low-dose aspirin users: data from a prospective multicenter capsule endoscopy registry.

Endo H, Sakai E, Taniguchi L, Kessoku T, Komiya Y, Ezuka A, Kawamura H, Taguri M, Higurashi T, Ohkubo H, Yamada E, Takahashi H, Inamori M, Maeda S, Sakaguchi T, Hata Y, Nagase H, Nakajima A.

Gastrointest Endosc. 2014 Nov;80(5):826-34. doi: 10.1016/j.gie.2014.03.024.

PMID:
24830581
13.

Aspirin-induced small bowel injuries and the preventive effect of rebamipide.

Mizukami K, Murakami K, Abe T, Inoue K, Uchida M, Okimoto T, Kodama M, Fujioka T.

World J Gastroenterol. 2011 Dec 14;17(46):5117-22. doi: 10.3748/wjg.v17.i46.5117.

14.

Proximal predominance of small bowel injury associated with uncoated low-dose aspirin therapy: a video capsule study in chronic users.

Ehrhard F, Nazeyrollas P, Brixi H, Heurgue-Berlot A, Thiéfin G.

Eur J Gastroenterol Hepatol. 2013 Nov;25(11):1265-72. doi: 10.1097/MEG.0b013e3283640fad.

PMID:
23873021
15.

Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo.

Goldstein JL, Eisen GM, Lewis B, Gralnek IM, Zlotnick S, Fort JG; Investigators..

Clin Gastroenterol Hepatol. 2005 Feb;3(2):133-41.

PMID:
15704047
16.

[Gastrointestinal tolerance of 30 mg versus 300 mg acetylsalicylic acid daily. An endoscopically controlled double-blind study of healthy subjects].

Müller P, Dammann HG, Marinis E, Simon B.

Med Klin (Munich). 1990 Jul 15;85(7):429-31. German.

PMID:
2385209
17.

Effectiveness of polaprezinc for low-dose aspirin-induced small-bowel mucosal injuries as evaluated by capsule endoscopy: a pilot randomized controlled study.

Watari I, Oka S, Tanaka S, Aoyama T, Imagawa H, Shishido T, Yoshida S, Chayama K.

BMC Gastroenterol. 2013 Jul 4;13:108. doi: 10.1186/1471-230X-13-108.

18.

Combination of low-dose aspirin and thienopyridine exacerbates small bowel injury.

Shiotani A, Honda K, Murao T, Ishii M, Fujita M, Matsumoto H, Tarumi K, Kamada T, Sakakibara T, Haruma K.

Scand J Gastroenterol. 2011 Mar;46(3):281-6. doi: 10.3109/00365521.2010.533381.

PMID:
21133822
19.

Acute damage of gastroduodenal mucosa by acetylsalicylic acid: no prolonged protection by antacids.

Berstad K, Haram EM, Weberg R, Berstad A.

Aliment Pharmacol Ther. 1989 Dec;3(6):585-90.

PMID:
2518872
20.

Characteristics of small bowel injury in symptomatic chronic low-dose aspirin users: the experience of two medical centers in capsule endoscopy.

Endo H, Hosono K, Inamori M, Nozaki Y, Yoneda K, Fujita K, Takahashi H, Yoneda M, Abe Y, Kirikoshi H, Kobayashi N, Kubota K, Saito S, Ohya T, Hisatomi K, Teratani T, Matsuhashi N, Nakajima A.

J Gastroenterol. 2009;44(6):544-9. doi: 10.1007/s00535-009-0040-z.

PMID:
19373431
Items per page

Supplemental Content

Support Center